Stock UniverseDerived research view · source repositories remain read-only

Perrigo Company plc (PRGO)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
31.81
Global Rank
1689
Market Cap
1.82B
Latest Close
10.83
RS Composite
-10.41% · G#2117

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-9.37%
3M
1.03%
6M
-20.68%
1Y
-57.31%
3Y
-61.80%
5Y
-72.07%
10Y
-85.70%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.50M · 30-day average: 2.53M · Max drawdown over stored range: -89.17%

Research Snapshot

Relative Strength vs SPX

RS Composite-10.41%
20D RS-5.83%
60D RS1.43%
120D RS-24.55%
Global RS Rank2117 · 36.90% percentile
Watch+Speculative RS Rank1325 · 36.81% percentile
Group ScopeWatch+Speculative
Primary RS Rank208 · 54.59% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank205 / 701
Primary Percentile70.90
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-282026-05-064.18B1.43B-1.54B-1.82B-13.14136.30M151.90M-15.60M138M34.17%-36.89%-43.50%3.26%-0.37%357.20M3.62B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-28$-13.14-0.8x$30.200.4x$-0.11-96.0x$0.9911.0x

Shares Diluted: 138M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue4138.74451.64655.64373.44253.1
Revenue Growth (YoY)1.235%7.56%4.583%-6.062%-2.751%
Gross Profit1416.21479.21680.41542.71494.5
Operating Income603.4192.9288.6321.3375.8
Free Cash Flow-66.4210.9303.8231.3143.6
Free Cash Flow Per Share-0.4971.5682.2451.6831.037
EPS (Diluted) GAAP-0.515928-1.045353-0.093865-1.250786-10.291696
EPS Growth
EPS Non-GAAP
Gross Margin34.218%33.228%36.094%35.275%35.139%
Operating Margin14.579%4.333%6.199%7.347%8.836%
Profit Margin-1.665%-3.158%-0.273%-3.928%-33.514%
Free Cash Flow Margin-1.604%4.738%6.525%5.289%3.376%
Shares Outstanding (Diluted)133.6134.5135.3137.4138.5
Shares Change (YoY)-2.624%0.674%0.595%1.552%0.801%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06969.20M33.58%-372.30M-38.41%-398.60M-41.13%-2.87138.70M357.20M3.62Bprocessed
2025 Q42026-02-261.11B32.64%-1.29B-1.16%-1.42B-1.28%-10.31137.60M531.60M3.60Bprocessed
2025 Q32025-11-051.04B36.14%72.60M6.96%7.50M0.72%0.05138.90M432.10M3.61Bprocessed
2025 Q22025-08-061.06B34.36%45.40M4.30%-8.40M-0.80%-0.06138.20M454.20M3.62Bprocessed
2025 Q12025-05-071.04B37.58%46.90M4.49%-6.40M-0.61%-0.05137.70M409.90M3.59Bprocessed
2024 Q42025-02-281.14B33.90%114.20M10.03%-44.50M-3.91%-0.32137.70M558.80M3.58Bprocessed
2024 Q32024-11-061.09B37.19%80.40M7.39%-21.00M-1.93%-0.15137.50M1.46B4.31Bprocessed
2024 Q22024-08-021.07B37.04%-26.50M-2.49%-108.40M-10.17%-0.79137.10M542.80M3.62Bprocessed
2024 Q12024-05-071.08B33.06%-55.20M-5.10%2.00M0.18%0.01137.60M658.50M3.62Bprocessed
2023 Q42024-02-271.16B36.93%-15.60M-1.35%-32.30M-2.79%-0.25131.40M751.30M3.63Bprocessed
2023 Q32023-11-071.12B36.59%62.10M5.53%14.20M1.26%0.10136.90M598.30M4.05Bprocessed
2023 Q22023-08-081.19B35.87%56.80M4.76%8.40M0.70%0.06136.60M555.20M4.06Bprocessed
2023 Q12023-05-091.18B35.02%48.50M4.10%-3.00M-0.25%-0.02134.90M553.00M4.06Bprocessed
2022 Q42023-02-281.16B33.12%31.00M2.68%-45.70M-3.96%-0.34134.80M600.70M4.07Bprocessed
2022 Q32022-11-081.10B32.98%33.10M3.01%-49.40M-4.49%-0.37134.60M468.70M4.08Bprocessed
2022 Q22022-08-091.12B33.17%-6.90M-0.62%-65.10M-5.80%-0.48134.60M485.30M4.09Bprocessed
2022 FY2022-05-111.07B31.44%21.70M2.02%-2.40M-0.22%-0.02134.00M1.97B3.51Bprocessed
2021 Q42022-03-011.10B32.80%46.70M4.23%9.60M0.87%0.07133.90M1.86B2.92Bprocessed
2021 Q32021-11-121.04B32.26%438.30M42.04%-58.90M-5.65%-0.44133.80M2.08B2.92Bprocessed
2021 Q22021-08-11981.10M35.57%-125.90M-12.83%-57.70M-5.88%-0.43133.60M317.50M2.93Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.